Inhibition of premature oocyte maturation: a role for bone morphogenetic protein 15 in zebrafish ovarian follicles.
Bone morphogenetic protein-15 (BMP-15) is a member of the TGF-beta superfamily known to regulate ovarian functions in mammals. Recently, we cloned zebrafish BMP-15 (zfBMP-15) cDNA and demonstrated that it may play a role in oocyte maturation. In this study, we further investigated the role of BMP-15 in zebrafish follicular development and oocyte maturation using an antiserum developed for zfBMP-15 and by microinjection of follicles with antisense zfBMP-15 N-morpholino oligonucleotides or an expression construct containing zfBMP-15 cDNA. Injection with antiserum caused a significant decrease in maturation-incompetent [insensitive to maturation-inducing hormone (MIH)] early growth phase follicles and a concomitant increase in mature follicles in vivo. In vitro maturation assays showed that incubation with antiserum resulted in a significant increase in oocyte maturation as compared with follicles incubated in preimmune serum or media control. Next, early growth phase follicles were collected and preincubated with either antiserum, preimmune serum, or medium control before treatment with MIH or human chorionic gonadotropin (hCG). Antiserum significantly increased oocyte maturation in response to MIH, but not to hCG, and enhanced basal maturation rate in longer-term incubations. Knockdown of BMP-15 in early growth stage follicles with a BMP-15 antisense oligonucleotide resulted in increased oocyte maturation, whereas microinjection of BMP-15 cDNA into oocytes significantly reduced MIH- and hCG-induced oocyte maturation in normally competent, mid-growth-phase follicles. Collectively, these findings suggest that BMP-15 modulates follicular growth and prevents premature oocyte maturation in zebrafish, in part, by suppressing the sensitivity of follicles to MIH.
Department of Biology, York University, Toronto, Ontario, Canada.
Eric S
ES
Clelland
Qian
Q
Tan
Ari
A
Balofsky
Rosie
R
Lacivita
Chun
C
Peng
D000818:Animals; D030801:Animals, Genetically Modified; D055430:Bone Morphogenetic Protein 15; D048429:Cell Size / Q000187:drug effects; D005260:Female; D006062:Gonadotropins / Q000494:pharmacology; D055429:Growth Differentiation Factor 9; D006908:Hydroxyprogesterones / Q000494:pharmacology; D007106:Immune Sera / Q000494:pharmacology; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D008954:Models, Biological; D009865:Oocytes / Q000166:cytology* / Q000187:drug effects; D009866:Oogenesis / Q000187:drug effects / Q000235:genetics*; D006080:Ovarian Follicle / Q000166:cytology* / Q000187:drug effects / Q000254:growth & development; D014162:Transfection; D015027:Zebrafish; D029961:Zebrafish Proteins / Q000494:pharmacology
C525901:BMP15 protein, human; D055430:Bone Morphogenetic Protein 15; C525897:GDF9 protein, human; D006062:Gonadotropins; D055429:Growth Differentiation Factor 9; D006908:Hydroxyprogesterones; D007106:Immune Sera; D036341:Intercellular Signaling Peptides and Proteins; D029961:Zebrafish Proteins; C007433:17,20-dihydroxy-4-pregnen-3-one